Abstracts (HTML) List of Authors

Tacke, F

Soluble urokinase plasminogen activator receptor (suPAR) predicts outcome after resection of biliary tract cancer
NEMO prevents hepatocarcinogenesis independently of an IKK complex function by controlling liver regeneration

Tang, X

Schistosoma mansoni eggs modulate lipid metabolism in hepatocytes

Tanyildizi, Y

Distant metastases in patients with intrahepatic cholangiocarcinoma: Does location matter?

Taubert, R

Aberrant expression of activation regulators CBL-B, CTLA-4 and PD-1 in intrahepatic Teff cells in autoimmune hepatitis

Teng, H

Clomethiazole improves alcoholic fatty liver in patients admitted to the hospital for alcohol detoxification therapy

Teufel, A

BMP-9 modulates the hepatic responses to LPS

Thangapandi, VR

Loss of hepatic Mboat7 leads to liver fibrosis in an inflammation-independent manner

Thasler, WE

Expression and Function of Fibroblast Growth Factor 9 in hepatocellular carcinoma
Histone deacetylases (HDAC) expressions in HCC and functional effects of HDAC inhibitors in liver cancer cells

Thiess, L

The desmosomal cadherin desmoglein-2 regulates the Hippo pathway effector yes-associated protein (YAP) in liver cancer

Thimme, R

Progression of NAFLD and NASH is mediated by proinflammatory tissue-resident T cells
Blood reelin levels in the progression of chronic liver disease
HCV-specific CD4 T cells show strong Tfh functionality after DAA-mediated viral clearance
Cytokine patterns of newly identified HEV-specific CD4 T cell epitope
Metabolic programming of exhausted CD8+ T cells in chronic viral hepatitis
Persistence of a transcriptional chronic scar on HCV-specific CD8+ T cells after DAA-mediated antigen removal
TOX expression on HBV specific CD8+ T cells is linked to clinical stage of chronic HBV infection

Thomann, S

YAP-induced tumor initiation mediates a switch in hepatic macrophage identity via the Ccl2/Ccr2 axis

Thorgeirsson, S

Cancer stem cells as significant drivers of sorafenib resistance in hepatocellular carcinoma

Ticconi, F

LINC00152 drives a ceRNA network in human hepatocellular carcinoma

Tiegs, G

The alarmin IL-33 drives a ST2+ Treg-mediated anti-inflammatory immune response during immune-mediated hepatitis
Pyruvate kinase M2-deficiency in T cells leads to exacerbation of ConA hepatitis and alterations of T cell polarization
Soluble CEACAM1 induces activation of STAT5, Foxp3 expression and proliferation of Tregs in DC- T cell cocultures

Timrott, K

Transcriptional profiling of tumor-specific CD8 T cells shows contribution of TIGIT to T cell exhaustion in liver cancer

Tolosa, E

Single cell RNA sequencing reveals naïve T cells ready for effector function in livers of Primary Sclerosing Cholangitis

Torrecilla, S

Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC

Tóth, M

Hippo pathway effectors YAP and TAZ are opponents in the regulation of hepatic fibrosis
Dysregulation of Hippo/Yap signaling induces chromosome instability in intrahepatic cholangiocarcinoma
YAP-induced tumor initiation mediates a switch in hepatic macrophage identity via the Ccl2/Ccr2 axis

Trauner, M

Europäische Studie: Heterozygoter Alpha-1-Antitrypsinmangel (Pi*MZ) führt zu einem intermediären Leber-Phänotyp
Metabolische Veränderungen bei Erwachsenen mit homozygotem Alpha1-Antitrypsinmangel (Pi*ZZ Genotyp)
Die Therapie mit Alpha-1-Antitrypsin (AAT) assoziiert bei AAT-Mangel mit besseren Leber-bezogenen Parametern

Trautwein, C

Metabolic reprogramming in livers of mice with chronic liver disease
Europäische Studie: Heterozygoter Alpha-1-Antitrypsinmangel (Pi*MZ) führt zu einem intermediären Leber-Phänotyp
Metabolische Veränderungen bei Erwachsenen mit homozygotem Alpha1-Antitrypsinmangel (Pi*ZZ Genotyp)
Genetic or pharmacological inhibition of cyclin-dependent kinase 2 in Hepatic Stellate Cells acts anti-fibrotic
Soluble urokinase plasminogen activator receptor (suPAR) predicts outcome after resection of biliary tract cancer
Genetic fine analysis of the pro-fibrotic and pro-carcinogenic functions of Cyclin E1 in the liver
Extracellular vesicles from steatotic hepatocytes influence stellate cells in liver fibrosis
Absence of JNK activity in hepatocytes exacerbates liver injury and fibrosis during chronic cholestasis in mice
Die Therapie mit Alpha-1-Antitrypsin (AAT) assoziiert bei AAT-Mangel mit besseren Leber-bezogenen Parametern
RIPK1 and MLKL in hepatocytes do not mediate Concanavalin A (ConA)-mediated liver toxicity
NEMO prevents hepatocarcinogenesis independently of an IKK complex function by controlling liver regeneration
Macrophage Migration Inhibitory Factor promotes HCC progression in vivo via the receptor CD74
Intestinal dysbiosis amplifies acetaminophen induced acute liver injury
The NRF2/KEAP1 pathway in hepatocytes controls fibro- and carcinogenesis in chronic liver disease
The role of ferroptosis in chronic liver disease

Trebicka, J

Low muscle mass and large portosystemic shunt in “one-stop shop” CT exponentially increases risk for HE and mortality
Systemic inflammation is associated with hyperdynamic circulation and predicts acute-on-chronic liver failure

Truckenmueller, F

Quantitative LC-MS-based shot gun proteomics identifies deregulated proteins in gallbladder carcinoma

Tschuschner, A

M30 als Biomarker für die nicht-invasive NAFLD-Diagnostik bei Patienten mit morbider Adipositas nach Roux-y-Magenbypass

Tuma-Kellner, S

Deletion of fatty acid transport protein 4 in HepG2 cells increases lipolysis lipids and lipoprotein secretion
Intestinal deletion of fatty acid transport protein 4 in mice increases blood chylomicrons
Macrophage-specific Pla2G6 deficiency modulates bone marrow Ly6C levels and APAP liver injury in a sex-dependent manner

Turco, L

Systemic inflammation is associated with hyperdynamic circulation and predicts acute-on-chronic liver failure